SFS
MRNA icon

Strategic Financial Services’s Moderna MRNA Stock Holding History

Strategic Financial Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,680
Closed -$395K – 135
2021
Q2 		$395K Hold
1,680
– – 0.03% 102
2021
Q1 		$220K Buy
+1,680
New +$243K 0.02% 129

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Strategic Financial Services's MRNA Position: Q3 2021 in Review

Strategic Financial Services sold out of Moderna (MRNA) in Q3 2021, closing a stake of 1,680 shares — an estimated $395K sold.

Strategic Financial Services first reported a position in MRNA in Q1 2021 and held it in 2 quarters. The position peaked at $395K in Q2 2021. 1,140 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • Strategic Financial Services reported no remaining Moderna position as of Q3 2021 after selling out during the quarter.
  • Strategic Financial Services sold 1,680 Moderna shares in Q3 2021, an estimated $395K.
  • Strategic Financial Services first reported a position in Moderna in Q1 2021 and held it in 2 quarters.
  • Strategic Financial Services's Moderna position peaked at $395K in Q2 2021.
  • 1,140 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on Strategic Financial Services's 13F filing for Q3 2021, filed 15 Nov 2021.